Loading...

Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board

ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active

By |2018-10-09T15:54:36+00:00October 9th, 2018|Spine, Top Stories|

Ossur Hf : Share buyback program completed

Reykjavík, 8 October 2018 On 6 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share buyback program was to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The

By |2018-10-08T18:24:58+00:00October 8th, 2018|Financial|

TranS1® Announces NICE Guidance for Approval of AxiaLIF® in the UK’s National Health System (NHS)

WILMINGTON, N.C., Sept. 18, 2018 /PRNewswire/ -- TranS1®, an innovator in spine technology development that pioneered the anterior retroperitoneal presacral approach utilizing the AxiaLIF® System, announced today that the UK's National Institute for Health and Care Excellence (NICE) published its Interventional Procedure Guidance recommendation for  transaxial interbody lumbosacral fusion for severe chronic low back pain.1 The guidance recommended that

By |2018-10-08T17:34:11+00:00October 8th, 2018|Spine|

Stryker’s Advanced Guidance Technologies announces partnerships with Synaptive Medical and Ziehm Imaging

KALAMAZOO, Michigan, USA, Oct. 8, 2018 /PRNewswire/ -- Stryker's Advanced Guidance Technologies business (formerly known as Stryker's Navigation business) announced today it has entered into strategic partnerships with Synaptive Medical and Ziehm Imaging, strengthening Stryker's position as a leader in surgical guidance. Through the partnership with Synaptive Medical, Stryker will offer the BrightMatter™ Plan software, which automatically generates

By |2018-10-08T16:08:51+00:00October 8th, 2018|Spine|

Additive Orthopaedics Announces Receipt of NJ CoVest Fund Award

LITTLE SILVER, N.J., Oct. 8, 2018 /PRNewswire/ -- Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, today announced it has been approved for the NJ CoVest Fund through the New Jersey Economic Development Authority (EDA). The Fund is designed to help emerging technology companies bridge the funding gap between product development and

By |2018-10-08T15:26:07+00:00October 8th, 2018|Financial|

Corin signs binding agreement for the acquisition of Global Orthopaedic Technology

Cirencester, UK Corin, backed by the Permira Funds is pleased to announce the signing of a binding agreement for the acqusition of Global Orthopaedic Technology Pty Ltd (“GOT”), the largest Australian-based orthopaedic implant designer and manufacturer. The acquisition will strengthen Corin’s position as a global leader in the hip and knee joint replacement market and

By |2018-10-05T22:52:17+00:00October 5th, 2018|Financial|

3D-Printed Implants Successful in Foot and Ankle Surgery

ROSEMONT, Illinois, Oct. 5, 2018 /PRNewswire-HISPANIC PR WIRE/ -- According to a new study published in Foot & Ankle International (FAI), advancements in three-dimensional (3D) printing have allowed foot and ankle orthopaedic surgeons to use custom-made implants for difficult foot and ankle cases. The implants offer a new approach to treat complex lower extremity pain and deformities. Researchers at Duke University Department of

By |2018-10-05T21:18:38+00:00October 5th, 2018|Extremities|

K2M Group Holdings, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders

LEESBURG, Va., Oct. 05, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the “Company” or “K2M”), announced today that it has set a record date and meeting date for a special meeting of its stockholders to, among other things, consider and vote on a proposal to adopt the previously announced Agreement and Plan

By |2018-10-05T16:04:39+00:00October 5th, 2018|Financial|

NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting

SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will highlight several of its latest spinal innovations to treat complex spinal deformities at the Scoliosis Research Society (SRS) Annual Meeting held October 10-13, 2018 in Bologna, Italy. As a

By |2018-10-05T15:23:26+00:00October 5th, 2018|Spine|

Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants

WALTHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock in an underwritten public offering. The offering is subject to

By |2018-10-04T22:24:30+00:00October 4th, 2018|Financial|